Document Detail


Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?
MedLine Citation:
PMID:  14580735     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sufficiently strong defibrillation shocks will cause temporary or permanent damage to the heart. Weak defibrillation shocks do not cause any damage to the heart but also do not defibrillate. A relevant and practical question is what range of shock energies is most likely to defibrillate while not causing damage to the heart. This question is most difficult to answer in the pre-hospital defibrillation setting where the patients' size and shape vary, placement of the defibrillation patches vary, and the etiology of their arrhythmia varies. Unlike internal defibrillators, which are tested at implantation, efficacy of an external defibrillator is determined only once, when it is most needed. This review discusses shock damage and dysfunction caused by monophasic waveforms as well as biphasic waveforms. Evidence is presented suggesting that for perfused hearts, the threshold for damage is well above any shock size delivered clinically. For non-perfused hearts, both in humans and animals, evidence is presented that monophasic shocks of up to 5 J/kg do not cause any more cardiac damage/dysfunction than that associated with smaller shocks and that much of this damage is caused by the ischemic period itself rather than the shock. Although many patients can be defibrillated with 150 J (2.2 J/kg) biphasic shocks, some patients may require biphasic shocks up to 360 J (5 J/kg) to be defibrillated. Studies still need to be performed comparing the efficacy and damaging effects of 360 J biphasic shocks to 150 J biphasic shocks. Until those studies are completed, it seems reasonable to use the same 360 J (5 J/kg) energy limit for biphasic shocks as for monophasic shocks.
Authors:
Gregory P Walcott; Cheryl R Killingsworth; Raymond E Ideker
Related Documents :
1225345 - Titrated energy cardioversion of patients on digitalis.
19327525 - Direct epicardial shock wave therapy improves ventricular function and induces angiogen...
1850785 - Myocardial distribution of indium-111-antimyosin fab in acute inferior and right ventri...
18423065 - Vasopressin in vasodilatory shock: is the heart in danger?
12464985 - Effects of nitroprusside on cardiac norepinephrine spillover and isovolumic left ventri...
20225775 - Clinical profile of patients presenting with acute st elevation myocardial infarction.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Resuscitation     Volume:  59     ISSN:  0300-9572     ISO Abbreviation:  Resuscitation     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-10-28     Completed Date:  2004-01-20     Revised Date:  2009-08-25    
Medline Journal Info:
Nlm Unique ID:  0332173     Medline TA:  Resuscitation     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  59-70     Citation Subset:  IM    
Affiliation:
Cardiac Rhythm Management Laboratory, Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Volker Hall B140, 1670 University Blvd., Birmingham, AL 35294, USA. gpw@crml.uab.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Electric Countershock / adverse effects*
Heart Diseases / etiology*
Humans
Myocardial Ischemia / complications
Grant Support
ID/Acronym/Agency:
HL-63775/HL/NHLBI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lessons from community based management of floodplain fisheries in Bangladesh.
Next Document:  Interposed abdominal compression CPR: a comprehensive evidence based review.